This weeks collection is focused on generics and features interesting content on the future of the generics industry, innovation, and comparing the generics and animal health industries.

This year’s Pharma Integrates will focus on “Strategically transforming Pharma business relationships” examining how strategic relationships are evolving and increasingly becoming a source of mutual competitive advantage.

Innovation is a word that's thrown around a lot these days, but it is necessary to survive and plan for the future as the generics industry is poised for significant change in the coming years.

NextLevel Pharma’s “Advancing clinical research in Turkey, the Middle East and North Africa” will bring together the local regulators and ethics committees, alongside experienced investigators and study personnel as well as clinical trial experts from pharma and CROs.

This event will discuss in detail viewpoints from various payers, HTAs, patient groups on the definition, measurement, validation and value of achieving various QOL improvements in several therapeutic areas. Furthermore, there will also be perspectives from the pharma industry of how they overcame challenges in researching and demonstrating QOL improvements to provide extra value to payers, physicians and patients.